Comparison of Chromogenic in Situ Hybridisation (CISH) with Immunohistochemistry (IHC) for the Detection of HER2 Status in Breast Cancer

被引：0
|
作者：
Desai, S. [1 ]
Shirsat, H. [1 ]
Epari, S. [1 ]
Bagal, R. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2009年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：659 / 660
页数：2
相关论文
共 50 条
  • [1] Characterisation of HER2 Status in DCIS Using Immunohistochemistry (IHC) and Chromogenic in situ Hybridisation (CISH)
    Miligy, I.
    Gaber, A.
    Toss, M. S.
    Al-Kawaz, A. A.
    Nolan, C. C.
    Diez-Rodriguez, M. A.
    Burrell, H.
    Ellis, I. O.
    Green, A. R.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2018, 245 : S5 - S5
  • [2] Comparison of immunohistochemistry and chromogenic in situ hybridisation for the determination of HER2 status in breast and gastric cancer.
    Shi, D.
    Zhang, G.
    Liang, X.
    Hou, J.
    Kang, S.
    Zhu, W.
    Chen, L.
    Zhou, Y.
    Li, X.
    Shao, Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S51 - S51
  • [3] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    L Arnould
    Y Denoux
    G MacGrogan
    F Penault-Llorca
    M Fiche
    I Treilleux
    M C Mathieu
    A Vincent-Salomon
    M O Vilain
    J Couturier
    British Journal of Cancer, 2003, 88 : 1587 - 1591
  • [4] Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
    Arnould, L
    Denoux, Y
    MacGrogan, G
    Penault-Llorca, F
    Fiche, M
    Treilleux, I
    Mathieu, MC
    Vincent-Salomon, A
    Vilain, MO
    Couturier, J
    BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1587 - 1591
  • [5] Her2 Amplification Status in Iranian Breast Cancer Patients: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridisation (FISH)
    Ghaffari, Saeed Reza
    Sabokbar, Tayebeh
    Dastan, Jila
    Rafati, Maryam
    Moossavi, Shirin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1031 - 1034
  • [6] Role of chromogenic in situ hybridization (CISH™) in the evaluation of HER2 status in breast carcinoma:: Comparison with immunohistochemistry and FISH
    Li-Ning-T, E
    Ronchetti, R
    Torres-Cabala, C
    Merino, MJ
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2005, 13 (04) : 343 - 351
  • [7] Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Kiyose, Shinichiro
    Igarashi, Hisaki
    Nagura, Kiyoko
    Kamo, Takaharu
    Kawane, Kazunori
    Mori, Hiroki
    Ozawa, Takachika
    Maeda, Matsuyoshi
    Konno, Keisuke
    Hoshino, Hideaki
    Konno, Hiroyuki
    Ogura, Hiroyuki
    Shinmura, Kazuya
    Hattori, Naohiko
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 728 - 734
  • [8] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    MODERN PATHOLOGY, 2017, 30 : 505A - 505A
  • [9] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    LABORATORY INVESTIGATION, 2017, 97 : 505A - 505A
  • [10] Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer
    Di Palma, S.
    Collins, N.
    Faulkes, C.
    Ping, B.
    Ferns, G.
    Haagsma, B.
    Layer, G.
    Kissin, M. W.
    Cook, M. G.
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1067 - 1068
12345